
Blanquart Christophe
@blanquartchris4
ID: 1182339095705587713
10-10-2019 16:56:43
46 Tweet
25 Takipçi
32 Takip Edilen

Phase II study of EZH2 inhibitor tazemetostat in mesothelioma The Lancet Oncology. In 74pts with #MPM, 2 responses and DCR in #BAP1 inactivated #MPM was 54%. mPFS 18w and mOS 36w. thelancet.com/journals/lanon…






L'école d'été de LUNG_O2 c'est maintenant. CHU de Nantes l'institut du thorax @CR2TI_Nantes @Crci2naClub Centrale Nantes @UGustaveEiffel Nantes Université








A new Science Translational Medicine Viewpoint reviews recent developments in #immunotherapy for solid tumors and highlights progress in translational research and clinical practice. scim.ag/Ht




Nick Kanellakis MRC Toxicology Unit @rintoul_robert Cambridge University Royal Papworth Hospital NHS FT 💙 Closing out the organoid/spheroid session is Christophe Blanquart from Nantes Université...


🥂Read in #JExBio🥂Here Maureen Labbé et al present data that supports the existence of cellular mechanisms associated with TP53 mutations which control the non coding RNA content of small #EVs in melanoma. Read the full text here👉bit.ly/3r0CnxO


What a (macro) day! Thanks to all the speakers for their great presentations and the fruitful discussions! Gomez Perdiguero Lab@Pasteur @irset_fr Honeycomb Team @RMeS_UMR1229 @Crci2naClub @CR2TI_Nantes CEPR_Pathophysiology_Respiratory_Infections @ISPTours

